探索Interleukin-1在肺癌中的多方面的作用:从瘤发育到免疫调节
Mingbo Tang1, Yipeng Yin1, Wei Wang2
1Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Life sciences
|February 29, 2024
概括
瘤微环境 (TME) 中的介质素-1 (IL-1) 驱动肺癌的进展和免疫抑制. 在TME中准IL-1为这种致命疾病提供了一个有前途的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因,有效的治疗选择有限.
- 迟诊断,耐药性和复发等挑战阻碍了临床成功.
- 瘤微环境 (TME) 越来越被认为对癌症的发展和治疗耐药性至关重要.
研究的目的:
- 为了审查介质素-1 (IL-1) 在肺癌TME中的多方面的作用.
- 阐明IL-1对肺癌发生,入侵,转移和免疫规避的影响.
- 探索针对TME中的IL-1的新型治疗策略.
主要方法:
- 综合文献综述,重点关注IL-1在肺癌中的作用.
- 在TME内分析IL-1表达模式和功能.
- 评估IL-1对瘤与宿主免疫相互作用的影响.
主要成果:
- 在肺癌TME中,IL-1被各种细胞类型丰富地表达.
- IL-1促进炎症环境,支持瘤生长和进展.
- IL-1有助于肺癌的入侵,转移和免疫抑制.
结论:
- IL-1在肺癌的发病过程中起着重要而复杂的作用.
- 在TME内调节IL-1提供了一个潜在的治疗途径.
- 对IL-1向治疗的进一步研究可以克服目前肺癌治疗的局限性.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
433
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
